1 / 5

Potential mechanisms whereby statins may reduce the risk of stroke

Potential mechanisms whereby statins may reduce the risk of stroke. P. Amarenco, et al. Arch Med Sci 2007;3:S109-S114. Stroke risk reduction according to LDL-cholesterol reduction (%) in statin trials. P. Amarenco, et al. Arch Med Sci 2007;3:S109-S114.

wald
Download Presentation

Potential mechanisms whereby statins may reduce the risk of stroke

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Potential mechanisms whereby statins may reduce the risk of stroke P. Amarenco, et al. Arch Med Sci 2007;3:S109-S114

  2. Stroke risk reduction according to LDL-cholesterol reduction (%) in statin trials P. Amarenco, et al. Arch Med Sci 2007;3:S109-S114

  3. Net benefit of treatment with atorvastatin 80 mg/day in patients with recent stroke or transient ischemic attack (analysis of incidence of hemorrhagic stroke was post hoc) in the SPARCL trial Left panel: primary endpoint stroke fatal or non. Right panel: secondary endpoint major cardiovascular events (stroke fatal or non and major coronary events) P. Amarenco, et al. Arch Med Sci 2007;3:S109-S114

  4. Meta-analysis of four statin trials that evaluated the effect of intensive lipid-lowering therapy versus standard statin therapy: fatal and nonfatal stroke incidence P. Amarenco, et al. Arch Med Sci 2007;3:S109-S114

  5. Meta-analysis of four statin trial that evaluated the effect of intensive lipid-lowering therapy versus standard statin therapy: major cardiovascular events (including stroke, myocardial infarction and vascular death) P. Amarenco, et al. Arch Med Sci 2007;3:S109-S114

More Related